The European Commission said it approved an updated version of the Covid-19 vaccine developed by BioNTech-Pfizer, reported German news agency dpa.

The vaccine Comirnaty XBB.1.5-adapted has been altered for the third time to respond to new Covid-19 variants and was authorised for adults, children, and infants above six months, the commission said in a Friday press release...